1. Home
  2. AKTX vs MGIH Comparison

AKTX vs MGIH Comparison

Compare AKTX & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

HOLD

Current Price

$0.35

Market Cap

17.2M

Sector

Health Care

ML Signal

HOLD

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

N/A

Current Price

$1.34

Market Cap

17.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
AKTX
MGIH
Founded
N/A
1978
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
17.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AKTX
MGIH
Price
$0.35
$1.34
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.30
N/A
AVG Volume (30 Days)
1.3M
25.2K
Earning Date
11-13-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,334,149.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$1.11
52 Week High
$1.73
$6.83

Technical Indicators

Market Signals
Indicator
AKTX
MGIH
Relative Strength Index (RSI) 28.28 35.05
Support Level $0.42 $1.29
Resistance Level $0.50 $1.61
Average True Range (ATR) 0.08 0.16
MACD -0.00 0.00
Stochastic Oscillator 11.86 34.36

Price Performance

Historical Comparison
AKTX
MGIH

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

Share on Social Networks: